Skip to main content
Equibles

EP Wealth Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1540569 TORRANCE, CA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$811,225
-$304,467 QoQ
Shares Held
1,301
-9.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EP Wealth Advisors, LLC holds $18,108,847 across 26 Biotechnology names. REGN ranks #7 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 9,027 $4,483,981
2 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,135 $3,108,383
3 JAZZ
Jazz Pharmaceuticals plc
 6,385 $1,538,593
4 EXEL
Exelixis, Inc.
 23,865 $1,298,494
5 INCY
Incyte Corp
 10,863 $1,231,429
6 BNTX
BioNTech SE
 12,723 $1,183,875
7 REGN
Regeneron Pharmaceuticals, Inc.
This page 		1,301 $811,225
8 HALO
Halozyme Therapeutics, Inc.
 8,761 $685,723

All Filings in REGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $811,225 1,301
2026-03-31 $1,115,692 1,444
2025-12-31 $1,262,779 1,636
2025-06-30 $1,177,050 2,242
2025-03-31 $655,159 1,033
2024-12-31 $887,563 1,246
2024-09-30 $1,542,169 1,467
2024-06-30 $1,322,195 1,258
2024-03-31 $1,227,174 1,275
2023-12-31 $1,020,572 1,162
2023-09-30 $860,816 1,046
2023-06-30 $715,610 569,130
2023-03-31 $434,084 4,550,000
2022-12-31 $880,217 1,220
2022-03-31 $213,716 306